Applied Therapeutics logo
Applied Therapeutics APLT

Quarterly report 2025-Q3
added 11-13-2025

report update icon

Applied Therapeutics Total Current Liabilities 2011-2026 | APLT

Annual Total Current Liabilities Applied Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
71.2 M 33.4 M 26.5 M 21.2 M 14.1 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
71.2 M 14.1 M 33.3 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
5.75 M - 10.36 % $ 9.8 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
2.24 M $ 2.37 1.72 % $ 3.1 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
158 M $ 19.6 1.92 % $ 916 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
200 M - - $ 546 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Cara Therapeutics Cara Therapeutics
CARA
25.6 M - -3.03 % $ 260 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
132 M $ 10.35 2.88 % $ 755 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Phio Pharmaceuticals Corp. Phio Pharmaceuticals Corp.
PHIO
1.63 M $ 1.27 4.09 % $ 7.6 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.35 1.89 % $ 344 M britainBritain
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
20.7 M $ 8.23 0.61 % $ 110 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
149 M $ 47.4 2.09 % $ 4.26 B schweizSchweiz
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
6.27 M - -5.98 % $ 34.1 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
63 M - - $ 3.74 B usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
16.4 M $ 1.32 3.13 % $ 81 M usaUSA
PMV Pharmaceuticals PMV Pharmaceuticals
PMVP
11.4 M $ 1.39 -0.36 % $ 73 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
82.4 M - -4.8 % $ 255 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
29.2 M - - $ 40.5 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Prelude Therapeutics Incorporated Prelude Therapeutics Incorporated
PRLD
53 M $ 3.26 4.49 % $ 251 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
6.01 M $ 4.51 4.76 % $ 864 M canadaCanada
Homology Medicines Homology Medicines
FIXX
11.3 M - 0.77 % $ 53.4 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA